TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TriLink BioTechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11485
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TriLink BioTechnologies Inc (TriLink), a subsidiary of Maravai Life Sciences Inc, is a manufacturer of modified nucleic acid products. The company’s products include oligonucleotides, nucleotides, custom chemistry, DNA synthesis reagents, cleanamp PCR products, modified nucleoside triphosphates, phosphoramidites, conjugation reagaents, mRNA and long RNA, among others. It also provides modified compounds such as aminoallyl, biotin, and two fluoro nucleotides. TriLink provides services to researchers in the areas of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. Its products are used in research, diagnostics and therapeutic applications. The company markets its products through its distributors in Canada, Sweden, Belgium, Italy, France, the Netherlands, Germany, the UK, Ireland, Denmark, Finland, Norway and Sweden, the Czech Republic, China, Korea, Japan and Taiwan. TriLink is headquartered in San Diego, California, the US.

TriLink BioTechnologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
TriLink BioTech Enters into Distribution Agreement with inVentis 10
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 11
Licensing Agreements 12
TriLink BioTech Enters Into Licensing Agreement With QuantiBact 12
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 13
TriLink BioTechnologies Inc – Key Competitors 14
TriLink BioTechnologies Inc – Key Employees 15
TriLink BioTechnologies Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Sep 10, 2018: Maravai LifeSciences expands oligonucleotide business, leases new facility for TriLink BioTechnologies 17
Corporate Communications 18
May 01, 2018: Maravai LifeSciences Expands Top Management Team with Four New Hires 18
Nov 27, 2017: TriLink BioTechnologies Names Michael Houston As New Chief Scientific Officer 19
Other Significant Developments 20
Sep 10, 2018: Maravai LifeSciences expands oligonucleotide business, leases new facility for TriLink BioTechnologies 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TriLink BioTech Enters into Distribution Agreement with inVentis 10
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 11
TriLink BioTech Enters Into Licensing Agreement With QuantiBact 12
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 13
TriLink BioTechnologies Inc, Key Competitors 14
TriLink BioTechnologies Inc, Key Employees 15

List of Figures
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • OMEICOS Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary OMEICOS Therapeutics GmbH (OMEICOS) is a biopharmaceutical company that develops small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. The company utilizes its proprietary technology of the body’s own omega-3 fatty acid metabolic processes to …
  • Hikma Pharmaceuticals Plc (HIK):企業の財務・戦略的SWOT分析
    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • OJSC IC Allianz :企業の戦略・SWOT・財務情報
    OJSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary OJSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Robert Bosch GmbH:企業の戦略・SWOT・財務分析
    Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report Summary Robert Bosch GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EL Sewedy Electric Co (SWDY):企業の財務・戦略的SWOT分析
    EL Sewedy Electric Co (SWDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務情報
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Yapi ve Kredi Bankasi A.S.:戦略・SWOT・企業財務分析
    Yapi ve Kredi Bankasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Yapi ve Kredi Bankasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hung Hing Printing Group Limited:企業の戦略・SWOT・財務情報
    Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Energen Corp (EGN):石油・ガス:M&Aディール及び事業提携情報
    Summary Energen Corp (Energen) is an oil and gas company that offers exploration and production programs. The company through its subsidiary, Energen Resources Corporation, is involved in the development, acquisition, exploration, and production of oil, natural gas, and natural gas liquids located i …
  • Dentsply Sirona, Inc.:企業の戦略・SWOT・財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Tissue Regenix Ltd:企業の製品パイプライン分析
    Summary Tissue Regenix Ltd (Tissue Regenix), a subsidiary of Tissue Regenix Group PLC, is a medical technology company that offers replacement body parts from biological materials by using the dCELL technology platform. The company’s proprietary dCELL technology process is applied in markets such as …
  • Matisa Materiel Industriel S.A.
    Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report Summary Matisa Materiel Industriel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ingredion Incorporated:企業の戦略・SWOT・財務情報
    Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆